May 7, 2021

SARS-CoV-2 Infection and Reinfection in a Seroepidemiological  Workplace Cohort in the United States

Category: Article Summary

Topic: Vaccines and Immunity

Keywords (Tags): re-infection

•  [Pre-print, not peer-reviewed] A prospective cohort study of SpaceX employees (N=4,111) found a 91% lower odds of SARS-CoV-2 reinfection over 6 months of follow-up among participants with  detectable SARS-CoV-2 antibodies at baseline. The study authors adjusted for underlying health  conditions and increased risk of exposure as potential confounders. The results suggest that previous infection may provide at least 6 months of protection from SARS-CoV-2 reinfection for  most individuals. 

Finch et al. (May 6, 2021). SARS-CoV-2 Infection and Reinfection in a Seroepidemiological  Workplace Cohort in the United States. Pre-print downloaded May 7 from  https://doi.org/10.1101/2021.05.04.21256609